| Home > Articles > Published articles > Writers, readers and erasers of RNA modifications in cancer |
| Date: | 2020 |
| Abstract: | Although cancer was originally considered a disease driven only by genetic mutations, it has now been proven that it is also an epigenetic disease driven by DNA hypermethylation-associated silencing of tumor suppressor genes and aberrant histone modifications. Very recently, a third component has emerged: the so-called epitranscriptome understood as the chemical modifications of RNA that regulate and alter the activity of RNA molecules. In this regard, the study of genetic and epigenetic disruption of the RNA-modifying proteins is gaining momentum in advancing our understanding of cancer biology. Furthermore, the development of epitranscriptomic anticancer drugs could lead to new promising and unexpected therapeutic strategies for oncology in the coming years. |
| Grants: | Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-1080 Agencia Estatal de Investigación RTI2018-094049-B-I00 Ministerio de Ciencia e Innovación SAF2014-55000 |
| Note: | Altres ajuts: MEFP/FPU17-02423 |
| Rights: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades. |
| Language: | Anglès |
| Document: | Article de revisió ; Article ; Versió publicada |
| Subject: | Epigenetics ; RNA modifications ; RNA-Editing ; RNA-Modifying enzymes |
| Published in: | Cancer Letters, Vol. 474 (january 2020) , p. 127-137, ISSN 1872-7980 |
11 p, 1.8 MB |